APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Betahistine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Betahistine Industry Growth and Trends Forecast to 2032

Report ID 173970080119 December 2025102 pages

Choose your research edition.

Industry ResearchBetahistine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Betahistine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Betahistine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Betahistine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Betahistine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Betahistine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Betahistine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Betahistine include TOWA PHARMACEUTICAL CO., LTD, Takeda Pharmaceutical Company Limited, Mylan, Orion Corporation, Nichi-Iko Pharmaceutical, HENNIG ARZNEIMITTEL GmbH & Co. KG, EA Pharma Co., Ltd., DOC Generici and Disphar International B.V., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Betahistine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Betahistine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Betahistine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Betahistine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Betahistine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Betahistine Market by Company

TOWA PHARMACEUTICAL CO., LTD

Takeda Pharmaceutical Company Limited

Mylan

Orion Corporation

Nichi-Iko Pharmaceutical

HENNIG ARZNEIMITTEL GmbH & Co. KG

EA Pharma Co., Ltd.

DOC Generici

Disphar International B.V.

Ciclum Farma Unipessoal

Betahistine Segment by Type

8mg

25mg

Others

Betahistine Segment by Application

Cerebral Thrombosis

Cerebral Embolism

Others

Betahistine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Betahistine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Betahistine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Betahistine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Betahistine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Betahistine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 8mg Table 2. Major Company of 25mg Table 3. Major Company of Others Table 4. Global Betahistine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Betahistine Sales by Type (2021-2026) & (K Units) Table 6. Global Betahistine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Betahistine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Betahistine Sales Market Share in Value by Type (2021-2026) Table 9. Global Betahistine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Betahistine Sales by Type (2027-2032) & (K Units) Table 11. Global Betahistine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Betahistine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Betahistine Sales Market Share in Value by Type (2027-2032) Table 14. Global Betahistine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Betahistine Sales by Type (2021-2026) & (K Units) Table 16. North America Betahistine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Betahistine Sales by Type (2021-2026) & (K Units) Table 18. Europe Betahistine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Betahistine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Betahistine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Betahistine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Betahistine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Betahistine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Betahistine Sales by Type (2021-2026) & (US$ Million) Table 25. Betahistine Industry Trends Table 26. Betahistine Industry Drivers Table 27. Betahistine Industry Opportunities and Challenges Table 28. Betahistine Industry Restraints Table 29. Global Betahistine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Betahistine Revenue Market Share by Company (2021-2026) Table 31. Global Betahistine Sales by Company (2021-2026) & (K Units) Table 32. Global Betahistine Sales Share by Company (2021-2026) Table 33. Global Betahistine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Betahistine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Betahistine Major Company Production Sites and Headquarters Table 36. Global Betahistine Company, Product Type & Application Table 37. Global Betahistine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Betahistine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Betahistine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Betahistine Sales by Region (2021-2026) & (K Units) Table 42. Global Betahistine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Betahistine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Betahistine Sales Market Share in Value by Region (2021-2026) Table 45. Global Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Betahistine Sales by Region (2027-2032) & (K Units) Table 47. Global Betahistine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Betahistine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Betahistine Sales Market Share in Value by Region (2027-2032) Table 50. Global Betahistine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Betahistine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Betahistine Sales by Application (2021-2026) & (K Units) Table 53. Global Betahistine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Betahistine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Betahistine Sales Market Share in Value by Application (2021-2026) Table 56. Global Betahistine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Betahistine Sales by Application (2027-2032) & (K Units) Table 58. Global Betahistine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Betahistine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Betahistine Sales Market Share in Value by Application (2027-2032) Table 61. Global Betahistine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Betahistine Sales by Application (2021-2026) & (K Units) Table 63. North America Betahistine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Betahistine Sales by Application (2021-2026) & (K Units) Table 65. Europe Betahistine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Betahistine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Betahistine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Betahistine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Betahistine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Betahistine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Betahistine Sales by Application (2021-2026) & (US$ Million) Table 72. TOWA PHARMACEUTICAL CO., LTD Company Information Table 73. TOWA PHARMACEUTICAL CO., LTD Business Overview Table 74. TOWA PHARMACEUTICAL CO., LTD Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolio Table 76. TOWA PHARMACEUTICAL CO., LTD Recent Development Table 77. Takeda Pharmaceutical Company Limited Company Information Table 78. Takeda Pharmaceutical Company Limited Business Overview Table 79. Takeda Pharmaceutical Company Limited Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Takeda Pharmaceutical Company Limited Betahistine Product Portfolio Table 81. Takeda Pharmaceutical Company Limited Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Mylan Betahistine Product Portfolio Table 86. Mylan Recent Development Table 87. Orion Corporation Company Information Table 88. Orion Corporation Business Overview Table 89. Orion Corporation Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Orion Corporation Betahistine Product Portfolio Table 91. Orion Corporation Recent Development Table 92. Nichi-Iko Pharmaceutical Company Information Table 93. Nichi-Iko Pharmaceutical Business Overview Table 94. Nichi-Iko Pharmaceutical Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Nichi-Iko Pharmaceutical Betahistine Product Portfolio Table 96. Nichi-Iko Pharmaceutical Recent Development Table 97. HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information Table 98. HENNIG ARZNEIMITTEL GmbH & Co. KG Business Overview Table 99. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolio Table 101. HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Development Table 102. EA Pharma Co., Ltd. Company Information Table 103. EA Pharma Co., Ltd. Business Overview Table 104. EA Pharma Co., Ltd. Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. EA Pharma Co., Ltd. Betahistine Product Portfolio Table 106. EA Pharma Co., Ltd. Recent Development Table 107. DOC Generici Company Information Table 108. DOC Generici Business Overview Table 109. DOC Generici Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. DOC Generici Betahistine Product Portfolio Table 111. DOC Generici Recent Development Table 112. Disphar International B.V. Company Information Table 113. Disphar International B.V. Business Overview Table 114. Disphar International B.V. Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Disphar International B.V. Betahistine Product Portfolio Table 116. Disphar International B.V. Recent Development Table 117. Ciclum Farma Unipessoal Company Information Table 118. Ciclum Farma Unipessoal Business Overview Table 119. Ciclum Farma Unipessoal Betahistine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Ciclum Farma Unipessoal Betahistine Product Portfolio Table 121. Ciclum Farma Unipessoal Recent Development Table 122. North America Betahistine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Betahistine Sales by Country (2021-2026) & (K Units) Table 124. North America Betahistine Sales Market Share by Country (2021-2026) Table 125. North America Betahistine Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Betahistine Sales Market Share Forecast by Country (2027-2032) Table 127. North America Betahistine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Betahistine Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Betahistine Market Share by Country (2021-2026) Table 130. North America Betahistine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Betahistine Market Share Forecast by Country (2027-2032) Table 132. Europe Betahistine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Betahistine Sales by Country (2021-2026) & (K Units) Table 134. Europe Betahistine Sales Market Share by Country (2021-2026) Table 135. Europe Betahistine Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Betahistine Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Betahistine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Betahistine Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Betahistine Market Share by Country (2021-2026) Table 140. Europe Betahistine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Betahistine Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Betahistine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Betahistine Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Betahistine Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Betahistine Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Betahistine Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Betahistine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Betahistine Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Betahistine Market Share by Country (2021-2026) Table 150. Asia-Pacific Betahistine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Betahistine Market Share Forecast by Country (2027-2032) Table 152. Latin America Betahistine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Betahistine Sales by Country (2021-2026) & (K Units) Table 154. Latin America Betahistine Sales Market Share by Country (2021-2026) Table 155. Latin America Betahistine Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Betahistine Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Betahistine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Betahistine Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Betahistine Market Share by Country (2021-2026) Table 160. Latin America Betahistine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Betahistine Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Betahistine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Betahistine Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Betahistine Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Betahistine Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Betahistine Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Betahistine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Betahistine Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Betahistine Market Share by Country (2021-2026) Table 170. Middle East and Africa Betahistine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Betahistine Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Betahistine Distributors List Table 175. Betahistine Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Betahistine Image Figure 2. Global Betahistine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Betahistine Market Size (2021-2032) & (US$ Million) Figure 4. Global Betahistine Sales (2021-2032) & (K Units) Figure 5. 8mg Image Figure 6. Global 8mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 25mg Image Figure 8. Global 25mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Betahistine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Betahistine Market Share by Type 2025 VS 2032 Figure 13. North America Betahistine Sales Market Share in Volume by Type in 2025 Figure 14. North America Betahistine Sales Market Share in Value by Type in 2025 Figure 15. Europe Betahistine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Betahistine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Betahistine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Betahistine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Betahistine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Betahistine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Betahistine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Betahistine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Betahistine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cerebral Thrombosis Image Figure 26. Global Cerebral Thrombosis Sales YoY Growth (2021-2032) & (K Units) Figure 27. Cerebral Embolism Image Figure 28. Global Cerebral Embolism Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Betahistine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Betahistine Market Share by Application 2025 VS 2032 Figure 33. North America Betahistine Sales Market Share in Volume by Application in 2025 Figure 34. North America Betahistine Sales Market Share in Value by Application in 2025 Figure 35. Europe Betahistine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Betahistine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Betahistine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Betahistine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Betahistine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Betahistine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Betahistine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Betahistine Sales Market Share in Value by Application in 2025 Figure 43. North America Betahistine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Betahistine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Betahistine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Betahistine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Betahistine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Betahistine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Betahistine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Betahistine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Betahistine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Betahistine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Betahistine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Betahistine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Betahistine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Betahistine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Betahistine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Betahistine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Betahistine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Betahistine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Betahistine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Betahistine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Betahistine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Betahistine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 8mg
  • 25mg
  • Others
Applications
  • Cerebral Thrombosis
  • Cerebral Embolism
  • Others
Companies covered
  • TOWA PHARMACEUTICAL CO., LTD
  • Takeda Pharmaceutical Company Limited
  • Mylan
  • Orion Corporation
  • Nichi-Iko Pharmaceutical
  • HENNIG ARZNEIMITTEL GmbH & Co. KG
  • EA Pharma Co., Ltd.
  • DOC Generici
  • Disphar International B.V.
  • Ciclum Farma Unipessoal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Betahistine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Betahistine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Betahistine Market by Type
  6. 1.3.1 8mg
  7. 1.3.2 25mg
  8. 1.3.3 Others
  9. 1.4 Global Betahistine Market Size by Type
  10. 1.4.1 Global Betahistine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Betahistine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Betahistine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Betahistine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Betahistine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Betahistine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Betahistine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Betahistine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Betahistine Industry Trends
  2. 2.2 Betahistine Industry Drivers
  3. 2.3 Betahistine Industry Opportunities and Challenges
  4. 2.4 Betahistine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Betahistine Revenue (2021-2026)
  2. 3.2 Global Top Players by Betahistine Sales (2021-2026)
  3. 3.3 Global Top Players by Betahistine Price (2021-2026)
  4. 3.4 Global Betahistine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Betahistine Major Company Production Sites & Headquarters
  6. 3.6 Global Betahistine Company, Product Type & Application
  7. 3.7 Global Betahistine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Betahistine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Betahistine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Betahistine Tier 1, Tier 2, and Tier 3
4 Betahistine Regional Status and Outlook
  1. 4.1 Global Betahistine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Betahistine Historic Market Size by Region
  3. 4.2.1 Global Betahistine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Betahistine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Betahistine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Betahistine Forecasted Market Size by Region
  7. 4.3.1 Global Betahistine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Betahistine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Betahistine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Betahistine by Application
  1. 5.1 Betahistine Market by Application
  2. 5.1.1 Cerebral Thrombosis
  3. 5.1.2 Cerebral Embolism
  4. 5.1.3 Others
  5. 5.2 Global Betahistine Market Size by Application
  6. 5.2.1 Global Betahistine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Betahistine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Betahistine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Betahistine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Betahistine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Betahistine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Betahistine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Betahistine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 TOWA PHARMACEUTICAL CO., LTD
  2. 6.1.1 TOWA PHARMACEUTICAL CO., LTD Company Information
  3. 6.1.2 TOWA PHARMACEUTICAL CO., LTD Business Overview
  4. 6.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 TOWA PHARMACEUTICAL CO., LTD Betahistine Product Portfolio
  6. 6.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Developments
  7. 6.2 Takeda Pharmaceutical Company Limited
  8. 6.2.1 Takeda Pharmaceutical Company Limited Company Information
  9. 6.2.2 Takeda Pharmaceutical Company Limited Business Overview
  10. 6.2.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Pharmaceutical Company Limited Betahistine Product Portfolio
  12. 6.2.5 Takeda Pharmaceutical Company Limited Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Betahistine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Betahistine Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Orion Corporation
  20. 6.4.1 Orion Corporation Company Information
  21. 6.4.2 Orion Corporation Business Overview
  22. 6.4.3 Orion Corporation Betahistine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Orion Corporation Betahistine Product Portfolio
  24. 6.4.5 Orion Corporation Recent Developments
  25. 6.5 Nichi-Iko Pharmaceutical
  26. 6.5.1 Nichi-Iko Pharmaceutical Company Information
  27. 6.5.2 Nichi-Iko Pharmaceutical Business Overview
  28. 6.5.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Nichi-Iko Pharmaceutical Betahistine Product Portfolio
  30. 6.5.5 Nichi-Iko Pharmaceutical Recent Developments
  31. 6.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
  32. 6.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Company Information
  33. 6.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Business Overview
  34. 6.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Product Portfolio
  36. 6.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments
  37. 6.7 EA Pharma Co., Ltd.
  38. 6.7.1 EA Pharma Co., Ltd. Company Information
  39. 6.7.2 EA Pharma Co., Ltd. Business Overview
  40. 6.7.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 EA Pharma Co., Ltd. Betahistine Product Portfolio
  42. 6.7.5 EA Pharma Co., Ltd. Recent Developments
  43. 6.8 DOC Generici
  44. 6.8.1 DOC Generici Company Information
  45. 6.8.2 DOC Generici Business Overview
  46. 6.8.3 DOC Generici Betahistine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 DOC Generici Betahistine Product Portfolio
  48. 6.8.5 DOC Generici Recent Developments
  49. 6.9 Disphar International B.V.
  50. 6.9.1 Disphar International B.V. Company Information
  51. 6.9.2 Disphar International B.V. Business Overview
  52. 6.9.3 Disphar International B.V. Betahistine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Disphar International B.V. Betahistine Product Portfolio
  54. 6.9.5 Disphar International B.V. Recent Developments
  55. 6.10 Ciclum Farma Unipessoal
  56. 6.10.1 Ciclum Farma Unipessoal Company Information
  57. 6.10.2 Ciclum Farma Unipessoal Business Overview
  58. 6.10.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ciclum Farma Unipessoal Betahistine Product Portfolio
  60. 6.10.5 Ciclum Farma Unipessoal Recent Developments
7 North America by Country
  1. 7.1 North America Betahistine Sales by Country
  2. 7.1.1 North America Betahistine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Betahistine Sales by Country (2021-2026)
  4. 7.1.3 North America Betahistine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Betahistine Market Size by Country
  6. 7.2.1 North America Betahistine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Betahistine Market Size by Country (2021-2026)
  8. 7.2.3 North America Betahistine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Betahistine Sales by Country
  2. 8.1.1 Europe Betahistine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Betahistine Sales by Country (2021-2026)
  4. 8.1.3 Europe Betahistine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Betahistine Market Size by Country
  6. 8.2.1 Europe Betahistine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Betahistine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Betahistine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Betahistine Sales by Country
  2. 9.1.1 Asia-Pacific Betahistine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Betahistine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Betahistine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Betahistine Market Size by Country
  6. 9.2.1 Asia-Pacific Betahistine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Betahistine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Betahistine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Betahistine Sales by Country
  2. 10.1.1 South America Betahistine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Betahistine Sales by Country (2021-2026)
  4. 10.1.3 South America Betahistine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Betahistine Market Size by Country
  6. 10.2.1 South America Betahistine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Betahistine Market Size by Country (2021-2026)
  8. 10.2.3 South America Betahistine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Betahistine Sales by Country
  2. 11.1.1 Middle East and Africa Betahistine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Betahistine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Betahistine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Betahistine Market Size by Country
  6. 11.2.1 Middle East and Africa Betahistine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Betahistine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Betahistine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Betahistine Value Chain Analysis
  2. 12.1.1 Betahistine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Betahistine Production Mode & Process
  7. 12.2 Betahistine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Betahistine Distributors
  10. 12.2.3 Betahistine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst